Patents by Inventor Anthony J. Nugent
Anthony J. Nugent has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11644410Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: GrantFiled: December 28, 2020Date of Patent: May 9, 2023Assignee: Labrador Diagnostics LLCInventors: Anthony J. Nugent, Daniel L. Young, Elizabeth A. Holmes, Michael Siegel, Ryan Wistort
-
Publication number: 20210223163Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: ApplicationFiled: December 28, 2020Publication date: July 22, 2021Applicant: Labrador Diagnostics LLCInventors: Anthony J. NUGENT, Daniel L. YOUNG, Elizabeth A. HOLMES, Michael SIEGEL, Ryan WISTORT
-
Patent number: 10876956Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: GrantFiled: May 2, 2017Date of Patent: December 29, 2020Assignee: Labrador Diagnostics LLCInventors: Anthony J. Nugent, Daniel L. Young, Elizabeth A. Holmes, Michael Siegel, Ryan Wistort
-
Patent number: 10557786Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: GrantFiled: May 19, 2016Date of Patent: February 11, 2020Assignee: Theranos IP Company, LLCInventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel Young, Elizabeth A. Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Publication number: 20170363536Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: ApplicationFiled: May 2, 2017Publication date: December 21, 2017Inventors: Anthony J. Nugent, Daniel L. Young, Elizabeth A. Holmes, Michael Siegel, Ryan Wistort
-
Publication number: 20160334403Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: ApplicationFiled: May 19, 2016Publication date: November 17, 2016Inventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel Young, Elizabeth A. Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Patent number: 9464981Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: GrantFiled: December 5, 2014Date of Patent: October 11, 2016Assignee: Theranos, Inc.Inventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel L. Young, Elizabeth A. Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Publication number: 20150185234Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: ApplicationFiled: December 5, 2014Publication date: July 2, 2015Inventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel L. Young, Elizabeth A. Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Publication number: 20120309636Abstract: The present invention provides systems, devices, and methods for point-of-care and/or distributed testing services. The methods and devices of the invention are directed toward automatic detection of analytes in a bodily fluid. The components of the device can be modified to allow for more flexible and robust use with the disclosed methods for a variety of medical, laboratory, and other applications. The systems, devices, and methods of the present invention can allow for effective use of samples by improved sample preparation and analysis.Type: ApplicationFiled: January 20, 2012Publication date: December 6, 2012Inventors: Ian Gibbons, Anthony J. Nugent, Anthony Delacruz, Daniel Young, Elizabeth Holmes, Andrew Drake, Timothy Michael Kemp, Sunny Balwani, Chinmay Pangarkar
-
Patent number: 7795038Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design prevents interference by reagents used for such removal with the HDL quantification reaction or with other assays carried out on the same sample. If desired, removal of non-HDL lipoproteins and assay of HDL cholesterol can be carried out without interruption of the assay.Type: GrantFiled: April 8, 2003Date of Patent: September 14, 2010Assignee: Cholestech CorporationInventors: Ronald M. Jones, Thomas E. Worthy, Jeffrey Shindelman, Neal F. Bellet, Anthony J. Nugent
-
Patent number: 7582484Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design is such that removal of non-HDL lipoproteins from a sample and assay of HDL cholesterol in the sample occur without interruption of the assay. The device also prevents interference by reagents used for the HDL assay with other assays carried out on the same sample.Type: GrantFiled: April 18, 2005Date of Patent: September 1, 2009Assignee: Cholestech CorporationInventors: Ronald M. Jones, Thomas E. Worthy, Anthony J. Nugent
-
Patent number: 7220595Abstract: An immunoassay cassette, apparatus, and method for detecting an analyte in a liquid body-fluid sample are disclosed. The cassette has a body and a support mounted on the body, for movement toward and away from a sample transfer position. Sample supplied to a sample well in the cassette body is taken up by a reagent reservoir containing a first reagent composition effective to form a modified sample. The support provides a reagent strip having a transfer zone that is brought into contact with the reservoir, when the support is in the transfer position, a detection zone located downstream of the transfer zone, and a second reagent composition effective to react with the modified sample to form a detectable analyte-dependent product. By controlling movement of the support, volume and rate of sample flow from the reservoir to the strip can be controlled to optimize and/or standardize sample-transfer conditions in the assay.Type: GrantFiled: June 6, 2003Date of Patent: May 22, 2007Assignee: Cholestech CorporationInventors: Anthony J. Nugent, Leanne M. Cowley, Neal F. Bellet, Jeffrey Shindelman, Michael E. Leos, Thomas E. Worthy, Kimberly Haley
-
Patent number: 6881581Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design is such that removal of non-HDL lipoproteins from a sample and assay of HDL cholesterol in the sample occur without interruption of the assay. The device also prevents interference by reagents used for the HDL assay with other assays carried out on the same sample.Type: GrantFiled: January 17, 2003Date of Patent: April 19, 2005Assignee: Cholestech CorporationInventors: Ronald M. Jones, Thomas E. Worthy, Anthony J. Nugent
-
Publication number: 20040029293Abstract: An immunoassay cassette, apparatus, and method for detecting an analyte in a liquid body-fluid sample are disclosed. The cassette has a body and a support mounted on the body, for movement toward and away from a sample transfer position. Sample supplied to a sample well in the cassette body is taken up by a reagent reservoir containing a first reagent composition effective to form a modified sample. The support provides a reagent strip having a transfer zone that is brought into contact with the reservoir, when the support is in the transfer position, a detection zone located downstream of the transfer zone, and a second reagent composition effective to react with the modified sample to form a detectable analyte-dependent product. By controlling movement of the support, volume and rate of sample flow from the reservoir to the strip can be controlled to optimize and/or standardize sample-transfer conditions in the assay.Type: ApplicationFiled: June 6, 2003Publication date: February 12, 2004Inventors: Anthony J. Nugent, Leanne M. Cowley, Neal F. Bellet, Jeffrey Shindelman, Michael E. Leos, Thomas E. Worthy, Kimberly Haley
-
Publication number: 20030224471Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design prevents interference by reagents used for such removal with the HDL quantification reaction or with other assays carried out on the same sample. If desired, removal of non-HDL lipoproteins and assay of HDL cholesterol can be carried out without interruption of the assay.Type: ApplicationFiled: April 8, 2003Publication date: December 4, 2003Inventors: Ronald M. Jones, Thomas E. Worthy, Jeffrey Shindelman, Neal F. Bellet, Anthony J. Nugent
-
Publication number: 20030166291Abstract: An assay device and method for measuring the concentration of HDL-associated cholesterol in a blood-fluid sample are described. The assay design is such that removal of non-HDL lipoproteins from a sample and assay of HDL cholesterol in the sample occur without interruption of the assay. The device also prevents interference by reagents used for the HDL assay with other assays carried out on the same sample.Type: ApplicationFiled: January 17, 2003Publication date: September 4, 2003Inventors: Ronald M. Jones, Thomas E. Worthy, Anthony J. Nugent